309 related articles for article (PubMed ID: 29473876)
1. Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.
Iyer AK; Jones KJ; Sanders VM; Walker CL
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473876
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.
Verma S; Khurana S; Vats A; Sahu B; Ganguly NK; Chakraborti P; Gourie-Devi M; Taneja V
Mol Neurobiol; 2022 Mar; 59(3):1502-1527. PubMed ID: 34997540
[TBL] [Abstract][Full Text] [Related]
4. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
Tremblay E; Martineau É; Robitaille R
J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
[TBL] [Abstract][Full Text] [Related]
5. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Clark JA; Southam KA; Blizzard CA; King AE; Dickson TC
J Chem Neuroanat; 2016 Oct; 76(Pt A):35-47. PubMed ID: 27038603
[TBL] [Abstract][Full Text] [Related]
6. Adipose-derived stem cell conditioned medium impacts asymptomatic peripheral neuromuscular denervation in the mutant superoxide dismutase (G93A) transgenic mouse model of amyotrophic lateral sclerosis.
Walker CL; Meadows RM; Merfeld-Clauss S; Du Y; March KL; Jones KJ
Restor Neurol Neurosci; 2018; 36(5):621-627. PubMed ID: 30010155
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.
Wong M; Martin LJ
Hum Mol Genet; 2010 Jun; 19(11):2284-302. PubMed ID: 20223753
[TBL] [Abstract][Full Text] [Related]
8. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
9. Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.
Cappello V; Francolini M
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28972545
[TBL] [Abstract][Full Text] [Related]
10. TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.
Lépine S; Castellanos-Montiel MJ; Durcan TM
Transl Neurodegener; 2022 Dec; 11(1):56. PubMed ID: 36575535
[TBL] [Abstract][Full Text] [Related]
11. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.
Arbour D; Tremblay E; Martineau É; Julien JP; Robitaille R
J Neurosci; 2015 Jan; 35(2):688-706. PubMed ID: 25589763
[TBL] [Abstract][Full Text] [Related]
12. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
[TBL] [Abstract][Full Text] [Related]
13. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
[TBL] [Abstract][Full Text] [Related]
14. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS).
Alhindi A; Boehm I; Chaytow H
J Anat; 2022 Nov; 241(5):1089-1107. PubMed ID: 34101196
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle in amyotrophic lateral sclerosis.
Shefner JM; Musaro A; Ngo ST; Lunetta C; Steyn FJ; Robitaille R; De Carvalho M; Rutkove S; Ludolph AC; Dupuis L
Brain; 2023 Nov; 146(11):4425-4436. PubMed ID: 37327376
[TBL] [Abstract][Full Text] [Related]
16. Immune response in peripheral axons delays disease progression in SOD1
Nardo G; Trolese MC; de Vito G; Cecchi R; Riva N; Dina G; Heath PR; Quattrini A; Shaw PJ; Piazza V; Bendotti C
J Neuroinflammation; 2016 Oct; 13(1):261. PubMed ID: 27717377
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
Dupuis L; Loeffler JP
Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
[TBL] [Abstract][Full Text] [Related]
18. Expression of a Mutant SEMA3A Protein with Diminished Signalling Capacity Does Not Alter ALS-Related Motor Decline, or Confer Changes in NMJ Plasticity after BotoxA-Induced Paralysis of Male Gastrocnemic Muscle.
Moloney EB; Hobo B; De Winter F; Verhaagen J
PLoS One; 2017; 12(1):e0170314. PubMed ID: 28103314
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.
Arbour D; Vande Velde C; Robitaille R
J Physiol; 2017 Feb; 595(3):647-661. PubMed ID: 27633977
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein nonmetastatic melanoma protein B ameliorates skeletal muscle lesions in a SOD1G93A mouse model of amyotrophic lateral sclerosis.
Nagahara Y; Shimazawa M; Tanaka H; Ono Y; Noda Y; Ohuchi K; Tsuruma K; Katsuno M; Sobue G; Hara H
J Neurosci Res; 2015 Oct; 93(10):1552-66. PubMed ID: 26140698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
